𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma

✍ Scribed by Kwong Wai Choy; Chi Pui Pang; Christopher B.O. Yu; Hing Lok Wong; Joan S.K. Ng; Dorothy S.P. Fan; Kwok Wai Lo; Joshua T.Y. Chai; Jianhua Wang; Weiling Fu; Dennis S.C. Lam


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
80 KB
Volume
20
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


We investigated sequence alternation, promoter methylation, and loss of heterozygosity (LOH) of the RB1 gene as possible mechanisms of its inactivation in retinoblastoma. In 42 Chinese patients with sporadic retinoblastoma, the promoter and entire coding region of RB1 were examined for sequence changes. Status of methylation of the CpG-rich island at the 5'end was determined by methylation specific PCR assay. We detected 15 RB1 mutations in 38% (16/42) of the retinoblastoma patients, among them 19% (8/42) were germ-line mutations. A total of nine novel mutations were identified: E54X, S114X, I126S, g73779insG, D718N, IVS2+1G>C, IVS14+1G>C, IVS21+1G>C, and a complex alteration g78177G>T/g78176insTT leading to 543X. Most of them are likely to affect the RB1large pocket domain through the production of truncated gene products. None of the DNA samples showed methylation at the RB1promoter. In 15 cases where both normal and cancerous retinoblastoma tissue specimens were available, allelic loss according to microsatellite markers within or distal to the RB1 locus was analyzed and immunohistological staining for RB1 expression performed. Among them, frequency of LOH at 13q14 was found to be high at 60% (9/15) with no segregation with unilateral tumors. All these nine tumors did not express RB1 protein, showing an association of LOH at the RB1 locus with its loss of expression in retinoblastoma. Our results indicate that the RB1 gene in sporadic retinoblastoma is commonly inactivated because of loss-of-function mutations and loss of heterozygosity but not by the epigenetic phenomenon of promoter hypermethylation.


πŸ“œ SIMILAR VOLUMES


Mutational screening of the RB1 gene in
✍ Velamakanni Saroj Kiran; Chitra Kannabiran; Kalyana Chakravarthi; Geeta K. Vemug πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 37 KB πŸ‘ 1 views

Retinoblastoma is the most common primary intraocular malignancy in children, caused by inactivation of the RB1 gene on chromosome 13. We carried out a mutational screen of the exons and promoter of the RB1 gene in Indian patients with retinoblastoma in order to determine the range of mutations givi

Erratum: mutational screening of the RB1
✍ Velamakanni Saroj Kiran; Chitra Kannabiran; Kalyana Chakravarthi; Geeta K. Vemug πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 10 KB πŸ‘ 1 views

lines 9-10: "Eight novel mutations were identified, including 4 single base changes…" This should read: "Eight novel mutations were identified, including 5 single base changes…" 2. Page 3, second line from bottom: "…(g.76940del12; IVS15del+20-33) extending from +18 to +32 of the intron (RB72)." Thi

Germline mutations of the POU6F2 gene in
✍ Daniela Perotti; Giovanna De Vecchi; Maria A. Testi; Elena Lualdi; Piergiorgio M πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 201 KB πŸ‘ 2 views

Wilms tumor (WT) is a kidney malignancy of childhood characterized by highly heterogeneous genetic alterations. We previously reported the molecular and cytogenetic characterization of a WT (Case 30) carrying an interstitial deletion in chromosome 7p14 between markers D7S555 and D7S668. Loss of hete

Sensitive multistep clinical molecular s
✍ Kim E. Nichols; Monisa D. Houseknecht; Lynn Godmilow; Greta Bunin; Carol Shields πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 466 KB

Retinoblastoma (RB) is a neoplasm of retinal origin caused by mutations in RB1, the retinoblastoma tumor suppressor gene. To facilitate genetics counseling and patient management, we adopted a multistep molecular screening assay for detecting RB1 mutations. This assay included DNA sequencing to iden